Scroll to top

2018 Announcements

CLINUVEL
Posted by CLINUVEL
December 19, 2018

CLINUVEL Vitiligo Communiqué

19 December 2018 As a depigmentation disorder hypomelanosis vitiligo is the most...

Read More
CLINUVEL
Posted by CLINUVEL
December 19, 2018

CUV103 Singaporean Phase II vitiligo study results

19 December 2018 SUMMARY Phase II study in vitiligo, a treatment-resistant disease1...

Read More
CLINUVEL
Posted by CLINUVEL
December 17, 2018

CLINUVEL Newsletter - December 2018

17 December 2018 As the year draws to a close we look back at...

Read More
CLINUVEL
Posted by CLINUVEL
November 21, 2018

Results of Meeting

21 November 2018 In accordance with Listing Rule 3.13.2 and section 251AA...

Read More
CLINUVEL
Posted by CLINUVEL
November 21, 2018

Managing Director AGM Presentation

21 November 2018 We have enjoyed the longest bull run in equities...

Read More
CLINUVEL
Posted by CLINUVEL
November 20, 2018

Chair's Address to the Annual General Meeting

21 November 2018 The value the market has placed on the Company...

Read More
CLINUVEL
Posted by CLINUVEL
November 5, 2018

CLINUVEL Newsletter - November 2018

05 November 2018 The most recent quarterly financial results (1 July-30 September...

Read More
CLINUVEL
Posted by CLINUVEL
October 31, 2018

Appendix 4C

Appendix 4C Melbourne, Australia and Leatherhead, UK, 31 October 2018 CLINUVEL PHARMACEUTICALS...

Read More
CLINUVEL
Posted by CLINUVEL
October 29, 2018

CLINUVEL expands Singapore laboratory facilities

 29 October 2018 CLINUVEL PHARMACEUTICALS LTD today announced that its fully owned...

Read More
CLINUVEL
Posted by CLINUVEL
October 18, 2018

Appendix 4G and Corporate Governance Statement

18 October 2018 This statement reports on the main corporate governance practices...

Read More
CLINUVEL
Posted by CLINUVEL
October 18, 2018

Notice of Annual General Meeting/Proxy Form

18 October 2018 This Explanatory Memorandum has been prepared for the Shareholders...

Read More
CLINUVEL
Posted by CLINUVEL
October 10, 2018

Appeal Upheld Against NICE Recommendation in England

10 October 2018 CLINUVEL PHARMACEUTICALS LTD today announced that the Appeal Panel...

Read More
CLINUVEL
Posted by CLINUVEL
October 8, 2018

Sachs 18th Biotech in Europe Forum Presentation

08 October 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...

Read More
CLINUVEL
Posted by CLINUVEL
October 5, 2018

Chair Letter to Shareholders

05 October 2018 This is a thank you to shareholders, investors, patients,...

Read More
CLINUVEL
Posted by CLINUVEL
October 4, 2018

Ceasing to be a substantial holder

04 October 2018 This is a notice regarding an individual or entity...

Read More
CLINUVEL
Posted by CLINUVEL
October 3, 2018

CLINUVEL Confirms AGM Date

03 October 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...

Read More
We use cookies to give you the best experience.